[VIDEO] Pfizer: Why Breast Cancer Awareness Should Not Be Taken Lightly
October is National Breast Cancer Awareness Month – 31 days dedicated to raising awareness of the disease and financial support for research to fight breast cancer – and the need to keep a steady awareness of the uncured disease remains vital.
Each year in the United States more than 200,000 women are diagnosed with breast cancer and more than 40,000 die from the disease. Men are not exempt as roughly 200,000 are also diagnosed yearly.
In 2014, the American Cancer Society estimates that there will be 232,670 new cases of invasive breast cancer and the World Health Organization hints at 15 million new cases worldwide.
But while advocacy for awareness of breast cancer seems to have become overrated – turning the month of October into a pink, over-played advertisement – health care professionals continue to remain heavily active in promoting awareness of the disease and attempting to diminish misconceptions.
Pfizer’s Chief Medical Officer Dr. Freda Lewis-Hall, M.D. recently visited the award-winning talk show The Doctors to dispel some of the misconceptions surrounding metastatic breast cancer.
“Today, we’re going to talk about metastatic breast cancer and this is a stage of cancer that not very many people know about,” said Dr. Lewis-Hall.
In a survey conducted by the pharma giant, Pfizer found that 60 percent of people surveyed knew little to nothing about metastatic breast cancer, raising concerns for health care professionals all around as early detection remains to be one of the key successes to proper treatment.
“Most deaths from breast cancer are from complications of recurrent or metastatic disease,” said Dr. Travis Stork, host of The Doctors and a board-certified emergency medicine physician.
“We conducted a recent study and…one of the other common misconceptions that we found in the survey was that people believed that metastatic breast cancer or advanced breast cancer was actually curable, and although early detection at any stage is really important, there’s no cure yet for metastatic breast cancer. That’s why it’s so very important to continue medical research,” said Dr. Lewis-Hall.
Dubai's new smart neuro spinal hospital: need to know
We take a look at Dubai's new smart hospital.
What: The Neuro Spinal Hospital and Radiosurgery Centre is a new hospital featuring state-of-the-art technology for spinal, neurosurgical, neurological, orthopaedic, radiosurgery and cancer treatments. The 700 million AED hospital, (equivalent to £138 million), has 114 beds, smart patient rooms, and green spaces for patient rehabilitation, and is four times the capacity of its former premises in Jumeirah. It is also the UAE’s first hospital to have surgical robots.
Where: The hospital is located in the Dubai Science Park. Founded in 2005, Dubai Science Park is home to more than 350 companies from multinational corporations in life sciences, biotechnology and research; over 4,000 people work here each day.
Who: The UAE's Neuro Spinal Hospital and Radiosurgery Centre was first established in Jumeirah in 2002 by Dr. Abdul Karim Msaddi, as the first as the first "super-specialty" neuroscience hospital.
Why: With advanced diagnosis and robotics, the hospital will provide care across neuroscience, spine, orthopaedics and oncology for people residing in the UAE, as well as international patients.
Prof. Abdul Karim Msaddi, Chairman and Medical Director of the hospital, said: “We are proud to bring world-class healthcare services to Dubai and believe our next-generation hospital will be a game-changer for the emirate’s and the region’s medical industry.
"It will not only significantly increase the availability of specialist neuroscience and radiosurgery treatments and provide better patient care but help attract and develop local and international talent. Investing in the new centre represents our continued faith in the resilience of the region’s economy, as well as a testament to our ongoing drive towards healthcare innovation in the UAE.”